ReNeuron 'confident' in stem cell therapy, despite delay
ReNeuron remains confident that its new stem cell therapy for stroke will be approved to start clinical trials, despite a request for further information from the industry regulator.
Archives for January 17, 2007
BG Medicine and Applied Biosystems collaborate on biomarker-guided drug discovery
BG Medicine will integrate Applied Biosystems' state of the art technology into its systems biology platforms to enhance its biomarker discovery and monitoring programs.
Pfizer planning more job cuts?
In response to mounting media speculation of another major restructuring drive, sparked off by an article in the Wall Street Journal (WSJ), Pfizer has called a meeting to discuss its strategic direction, with CEO Jeffrey B. Kindler hosting the meeting.
Celsis hopes for new business from FDA recognition
The US Food and Drug Administration has accepted two Celsis drug master files (DMFs) that could increase the adoption of its rapid microbiological detection technology among pharmaceutical manufacturers.
Sale of Owens-Illinois plastics business on the cards
The world's largest glass container manufacturer is considering hiving off its plastics packaging business as it reviews strategic options for the division.
Tocris Bioscience completes $40m management buy out
Tocris, a leading supplier of chemicals, peptides and antibodies to the major pharmaceutical companies, universities and research institutes has completed a $40m (€30.8m) management buy out (MBO) from its founders.
SAFC services sought by French biotech
SAFC will provide chemical development services for a new cancer treatment belonging to French biotech firm Affichem.
Indian firm plans more contract manufacturing space
A new Special Economic Zone (SEZ) is being created by Indian firm JB Chemicals & Pharmaceuticals for the contract manufacturing of active pharmaceutical ingredients (APIs), intermediates and finished drug formulations.
Injunction latest snag in FDA pedigree fiasco
A federal court judge has imposed a temporary injunction against the US Food and Drug Administration (FDA) over the organisation's drug 'pedigree' requirements, on the basis that the regulations leave sections of the supply chain unguarded and...
Oral drug delivery sector tipped for explosive growth
The rapidly growing market for oral drug delivery is forecast to increase 48 per cent to reach a $52.1 billion in revenues by 2010, with an annual growth rate of 10 per cent, according to a new study by Kalorama Information.
Reformulation trend capturing pharma
More and more drug makers are turning to reformulation to prolong the lifecycle of their top sellers and protect precious revenue from generic copies, as well as supplement dwindling pipelines.
War between Helix and shareholder continues
The current board of directors of Helix BioPharma is being challenged as the battle between management and one of the company's major shareholders continues.
Novo Nordisk stops small molecule drug development
Novo Nordisk has decided to stop developing small-molecule drugs and instead concentrate on protein-based therapies, capitalising on the strong growth in this sector of the pharmaceutical industry.
Quintiles launches its first US clinical trial network to tackle patient recruitment issues
Quintiles has teamed up with practices group Onmark to create a national clinical trial network comprised of Onmark members - a move that could help the CRO cope with increasing patient recruitment issues in the US.